Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2018
Pharma News, 2018
Secrets of mighty cancer killing virus unlocked by Otago researchers
University of Otago researchers have used high-resolution electron microscopy images to reveal how an anti-cancer virus interacts with tumor cells, increasing its potential to save lives.
Common blood pressure medication linked to greater lung cancer risk, study says
While hypertension medication can help lower blood pressure levels, it might also increase your risk of lung cancer, according to a new report.
Researchers explain how LSD changes perception
Psychedelic drugs such as LSD have a profound impact on human consciousness, particularly perception.
Careful, reps: Doctors are watching, FDA promo police's latest rebuke shows
The latest admonishment from the FDA's promo police is an unusual one.
Takeda tags another Shire drug for sale to win key nod for $62B deal
Takeda's top priority these days is securing its gigantic Shire buyout, even if it means giving up pieces of its portfolio to do it.
FDA refuses to approve Regeneron’s Eylea pre-filled syringe
The US Food and Drug Administration has refused to approve Regeneron’s pre-filled syringe version of eye-drug Eylea (aflibercept).
Eisai, Biogen Alzheimer's data fails to convince skeptics
(Reuters) - Eisai Co Ltd and partner Biogen Inc said on Thursday that the highest dose of their experimental Alzheimer’s disease drug showed effectiveness in a new analysis, but investors re...
Gilead raises outlook despite dip in revenue
Gilead's revenue beat analysts' expectations in Q3 2018, despite falling behind last year's results, leading the company to boost its earnings expectations for the year.
Lundbeck updates on clinical phase III study for Lu AF35700 in Treatment-Resistant Schizophrenia
Valby, Denmark, 25 October 2018 - H.
Gene therapy for Parkinson's symptoms shows promise
(HealthDay) — A new gene therapy might help improve motor symptoms in people with Parkinson's disease who aren't responding to other therapies, an early study has found.
Allopurinol linked to reduced risk for CKD stage ≥3 in gout
(HealthDay) — For patients with gout, allopurinol is associated with a reduced risk for developing chronic kidney disease stage ≥3, according to a study published online Oct.
Researchers discover drug that could combat brain cell death in those with Alzheimer’s disease
One of the hallmark traits of Alzheimer’s disease, a debilitating disorder marked by memory deficits and general cognitive decline, is the accumulation in the brain of a protein called b-amyloid.
9
10
11
12
13
14
15
16
17